Keith Murphy's most recent trade in VivoSim Labs Inc. was a trade of 574,923 Options (right to buy) done . Disclosure was reported to the exchange on Aug. 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VivoSim Labs Inc. | Keith Murphy | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 574,923 | 574,923 | - | - | Options (right to buy) | |
| VivoSim Labs Inc. | Keith Murphy | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 143,731 | 143,731 | - | - | Options (right to buy) | |
| VivoSim Labs Inc. | Keith Murphy | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 19,607 | 132,641 (0%) | 0% | 0 | Common Stock | |
| VivoSim Labs Inc. | Keith Murphy | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 19,607 | 93,427 (0%) | 0% | 0 | Common Stock | |
| VivoSim Labs Inc. | Keith Murphy | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| VivoSim Labs Inc. | Keith Murphy | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| VivoSim Labs Inc. | Keith Murphy | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| VivoSim Labs Inc. | Keith Murphy | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| TuHURA Biosciences Inc. | Keith Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2021 | 100,000 | 100,000 | - | - | Options (Right to Buy) | |
| VivoSim Labs Inc. | Keith Murphy | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| VivoSim Labs Inc. | Keith Murphy | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| VivoSim Labs Inc. | Keith Murphy | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| VivoSim Labs Inc. | Keith Murphy | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 20,000 | 66,320 (0%) | 0% | 0 | Common Stock | |
| TuHURA Biosciences Inc. | Keith Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 120,000 | 120,000 | - | - | Options (Right to Buy) | |
| VivoSim Labs Inc. | Keith Murphy | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| TuHURA Biosciences Inc. | Keith Murphy | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Aug 2020 | 181,010 | 181,010 (1%) | 1% | - | Common Stock |